Virginia Commonwealth University

VCU Massey Cancer Center

Renowned cell biologist and biochemist Lewis Cantley keynotes Massey’s annual Cancer Research Retreat

It was the Friday before Memorial Day Weekend, but that didn’t stop more than 140 attendees from participating in VCU Massey Cancer Center’s annual Cancer Research Retreat. Similar to past retreats, the morning featured lectures from Massey research members as well as a keynote address by cell biologist and biochemist Lewis Cantley, Ph.D., Margaret and Herman Sokol Professor in Oncology Research and director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. In the afternoon, more than 60 student researchers and postdoctoral fellows displayed abstracts in the poster session and competed for up to $250 in Excellence in Cancer Research Awards. 

Continue reading →

Massey partners with OncLive to raise awareness of cancer research and treatment

VCU Massey Cancer Center has formed a strategic partnership with OncLive® to give healthcare professionals and patients direct, timely access to important oncology research and clinical practice news from Massey and more than 30 other leading cancer centers, nursing schools and physician groups around the country via OncLive’s publications.

Continue reading →

Massey researcher selected as national leader for large-scale NCI clinical trial

Known as the NCI-MATCH trial – National Cancer Institute Molecular Analysis for Therapy Choice Program, the study will consist of numerous small, phase 2 trials that will examine solid tumors and lymphomas that no longer respond to standard treatment and have begun to grow. Next-generation DNA sequencing will be administered on tumor biopsies from as many as 3,000 patients nationwide to determine the cell’s “broken” mechanism and, therefore, what is causing the cancer growth.

Continue reading →

Massey researchers identify patients at risk for stem cell transplant complications

Researchers at VCU Massey Cancer Center’s Bone Marrow Transplant Program have recently published findings from a phase 2 clinical trial that demonstrate lymphocyte recovery in related and unrelated stem cell transplant recipients generally falls into three patterns that are significantly associated with survival. This first-of-its-kind research continues the efforts of principal investigator Amir Toor, M.D., to understand the immune system as a dynamical system that can be modeled to improve stem cell transplantation.  

Continue reading →

Common antibiotic part of a promising potential pancreatic cancer therapy

Paul Fisher and Bridget Quinn

Despite surgical advances, pancreatic cancer continues to be one of the most deadly and difficult cancers to manage due to a lack of effective therapies. However, VCU Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) scientists in the lab of Paul B. Fisher, M.Ph., Ph.D., are hoping to change that with a novel combination of an experimental drug and a common antibiotic that has shown promising results in preclinical experiments. 

Continue reading →